Search Within

Heiko Schoder

  1. "Weinberg Fellows"
Formats
  1. Meeting Abstract (25)
  2. Journal Article (17)
  3. Research Letter (1)
Groups
  1. Department of Medicine (43)
  2. Molecular Imaging and Therapy Service (43)
  3. Radiology, Department of (43)
  4. Weinberg Fellows (43)
  5. Survivorship Research (32)
  6. Hematologic Malignancies, Division of (25)

More Groups

People
  1. Colette Owens (19)
  2. Alison Moskowitz (18)
  3. Andrew Zelenetz (18)
  4. Anita Kumar (18)
  5. Paul Hamlin (18)
  6. Ariela Noy (16)

More People

Years
  1. 2025 (1)
  2. 2024 (11)
  3. 2023 (7)
  4. 2022 (5)
  5. 2021 (10)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Blood (11)
  3. Journal of Nuclear Medicine (4)
  4. Hematological Oncology (3)
  5. Pancreas (2)
  6. Blood Advances (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. American Society of Hematology (12)
  3. Society of Nuclear Medicine (4)
  4. Wiley Blackwell (4)
  5. Elsevier Inc. (2)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (43)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation
    Journal Article

    Epstein-Peterson, Z. D.; Drill, E.; Aypar, U.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamlin, P. A.; Ho, C.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Hypoxia-directed treatment of human papillomavirus-related oropharyngeal carcinoma
    Journal Article

    Lee, N. Y.; Sherman, E. J.; Schöder, H.; Wray, R.; Boyle, J. O.; Singh, B.; Grkovski, M.; Paudyal, R.; Cunningham, L.; Zhang, Z.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Retrospective characterization of nodal marginal zone lymphoma
    Journal Article

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Dogan, A.; Epstein-Peterson, Z. D.; Falchi, L.; Hamlin, P. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) in esophagogastric cancer using (89)Zr-trastuzumab PET: A pilot study
    Journal Article

    Lumish, M. A.; Maron, S. B.; Paroder, V.; Chou, J. F.; Capanu, M.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Lyashchenko, S. K.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity
    Journal Article

    Yu, Y.; Schöder, H.; Zakeri, K.; Chen, L.; Kang, J. J.; McBride, S. M.; Tsai, C. J.; Gelblum, D. Y.; Boyle, J. O.; Cracchiolo, J. R.; more...
    Oral Oncology (2023)

    Fulltext@MSK | Save
  • Interim analysis of a prospective validation of 2 blood-based genomic assessments (PPQ and NETest) to determine the clinical efficacy of (177)Lu-DOTATATE in neuroendocrine tumors
    Journal Article

    Bodei, L.; Raj, N.; Do, R. K.; Mauguen, A.; Krebs, S.; Reidy-Lagunes, D.; Schöder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era
    Research Letter

    Qualls, D.; Imber, B. S.; Okwali, M.; Hamlin, P. A.; Kumar, A.; Lahoud, O. B.; Matasar, M. J.; Noy, A.; Owens, C.; Zelenetz, A. D.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Ganesan, N.; Shah, G. L.; Wong, P.; Argyropoulos, K. V.; Sen, F.; Dogan, A.; Straus, D. J.; Noy, A.; Kumar, A.; more...
    Blood (2022)

    Fulltext@MSK | Save